189 related articles for article (PubMed ID: 9579641)
21. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
von Kries R; Stannigel H; Göbel U
Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
[TBL] [Abstract][Full Text] [Related]
22. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
Wisecarver JL; Haire WD
Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
[TBL] [Abstract][Full Text] [Related]
23. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
[TBL] [Abstract][Full Text] [Related]
24. [Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
Gotoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):571-80. PubMed ID: 3989338
[TBL] [Abstract][Full Text] [Related]
25. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.
Iba T; Nagaoka I; Boulat M
Thromb Res; 2013 May; 131(5):383-9. PubMed ID: 23566533
[TBL] [Abstract][Full Text] [Related]
26. The haematological manifestations of sepsis.
Mammen EF
J Antimicrob Chemother; 1998 Jan; 41 Suppl A():17-24. PubMed ID: 9511082
[TBL] [Abstract][Full Text] [Related]
27. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Saitoh D; Gando S; Thachil J
Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
[TBL] [Abstract][Full Text] [Related]
28. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
Cohendy R; Lefrant JY; de la Coussaye JE
Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
[No Abstract] [Full Text] [Related]
29. Perspectives for the future.
Mammen EF
Intensive Care Med; 1993; 19 Suppl 1():S29-34. PubMed ID: 8227736
[TBL] [Abstract][Full Text] [Related]
30. Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis.
Eisele B; Lamy M; Thijs LG; Keinecke HO; Schuster HP; Matthias FR; Fourrier F; Heinrichs H; Delvos U
Intensive Care Med; 1998 Jul; 24(7):663-72. PubMed ID: 9722035
[TBL] [Abstract][Full Text] [Related]
31. Observations during the treatment with antithrombin-III concentrate of a case of a tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin.
Jespersen J; Rasmussen NR; Toftgaard C
Thromb Res; 1982 Jun; 26(6):457-62. PubMed ID: 7112521
[No Abstract] [Full Text] [Related]
32. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis.
Dickneite G; Pâques EP
Thromb Haemost; 1993 Feb; 69(2):98-102. PubMed ID: 8456437
[TBL] [Abstract][Full Text] [Related]
33. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
34. Effects of pentoxifylline on coagulation profile and disseminated intravascular coagulation incidence in Egyptian septic neonates.
Adel M; Awad HA; Abdel-Naim AB; Al-Azizi MM
J Clin Pharm Ther; 2010 Jun; 35(3):257-65. PubMed ID: 20831528
[TBL] [Abstract][Full Text] [Related]
35. Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?
Iba T; Thachil J
Intensive Care Med; 2016 Jul; 42(7):1193-4. PubMed ID: 27143022
[No Abstract] [Full Text] [Related]
36. A Suggested Link Between Antithrombin Dose and Rate of Recovery from Disseminated Intravascular Coagulation in Patients with Severe Organ Failure.
Kuroda H; Tatsumi H; Sonoda T; Masuda Y
Clin Appl Thromb Hemost; 2022; 28():10760296221080942. PubMed ID: 35187966
[TBL] [Abstract][Full Text] [Related]
37. Disseminated intravascular coagulation in sepsis.
Zeerleder S; Hack CE; Wuillemin WA
Chest; 2005 Oct; 128(4):2864-75. PubMed ID: 16236964
[TBL] [Abstract][Full Text] [Related]
38. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
[TBL] [Abstract][Full Text] [Related]
39. Disseminated intravascular coagulation: What's new?
Levi M
Crit Care Clin; 2005 Jul; 21(3):449-67. PubMed ID: 15992667
[TBL] [Abstract][Full Text] [Related]
40. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
Vervloet MG; Thijs LG; Hack CE
Semin Thromb Hemost; 1998; 24(1):33-44. PubMed ID: 9515778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
